Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL experts Dr. John Gribben, Dr. Constantine Tam and Dr. William Wierda for a CLL roundtable to discuss the rationale behind treatment combinations. Note as they mention key factors such as toxicity overlap and statistical resistance.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement